Monday, July 27, 2009

Taro Receives FDA Approval for Cetirizine Hydrochloride Tablets (OTC) ANDA

Jul 27, 2009 - Taro Pharmaceutical Industries Ltd. reported today that it has received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for cetirizine hydrochloride tablets (OTC), 5 mg and 10 mg.

The details can be read here.

No comments: